Terry Suzanne Cohen

Array ( [id] => 4345846 [patent_doc_number] => 06284726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5' [patent_app_type] => 1 [patent_app_number] => 9/612126 [patent_app_country] => US [patent_app_date] => 2000-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 7841 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284726.pdf [firstpage_image] =>[orig_patent_app_number] => 612126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368931 [patent_doc_number] => 06274625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Anti-microbial compound' [patent_app_type] => 1 [patent_app_number] => 9/509805 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 3737 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274625.pdf [firstpage_image] =>[orig_patent_app_number] => 509805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274416 [patent_doc_number] => 06281013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Treatment of Infertility' [patent_app_type] => 1 [patent_app_number] => 9/528917 [patent_app_country] => US [patent_app_date] => 2000-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4354 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281013.pdf [firstpage_image] =>[orig_patent_app_number] => 528917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370298 [patent_doc_number] => 06288028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy' [patent_app_type] => 1 [patent_app_number] => 9/424414 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 17454 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288028.pdf [firstpage_image] =>[orig_patent_app_number] => 424414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290133 [patent_doc_number] => 06268473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => '.alpha.-conotoxin peptides' [patent_app_type] => 1 [patent_app_number] => 9/488799 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 16794 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268473.pdf [firstpage_image] =>[orig_patent_app_number] => 488799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187553 [patent_doc_number] => 06160097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Process for reactivating purified membrane proteins by freezing them' [patent_app_type] => 1 [patent_app_number] => 9/481699 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1702 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/160/06160097.pdf [firstpage_image] =>[orig_patent_app_number] => 481699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288827 [patent_doc_number] => 06268390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Therapeutic inhibitor of vascular smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 9/470662 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 40620 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268390.pdf [firstpage_image] =>[orig_patent_app_number] => 470662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352310 [patent_doc_number] => 06291428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Peptides which promote bone-forming cell attraction and adhesion' [patent_app_type] => 1 [patent_app_number] => 9/467423 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 19555 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291428.pdf [firstpage_image] =>[orig_patent_app_number] => 467423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262074 [patent_doc_number] => 06204360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Retro-inverso thymosin alpha 1 hybrids' [patent_app_type] => 1 [patent_app_number] => 9/465025 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6185 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204360.pdf [firstpage_image] =>[orig_patent_app_number] => 465025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385329 [patent_doc_number] => 06277974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death' [patent_app_type] => 1 [patent_app_number] => 9/461697 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 262 [patent_no_of_words] => 75976 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277974.pdf [firstpage_image] =>[orig_patent_app_number] => 461697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410118 [patent_doc_number] => 06228836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Permucous preparation' [patent_app_type] => 1 [patent_app_number] => 9/402886 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5629 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228836.pdf [firstpage_image] =>[orig_patent_app_number] => 402886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297909 [patent_doc_number] => 06184351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => '.alpha.-synuclein super-mutants accelerate .alpha.-synuclein aggregation' [patent_app_type] => 1 [patent_app_number] => 9/405035 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5183 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184351.pdf [firstpage_image] =>[orig_patent_app_number] => 405035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411300 [patent_doc_number] => 06310176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Antimicrobially active polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/319730 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6592 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310176.pdf [firstpage_image] =>[orig_patent_app_number] => 319730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317891 [patent_doc_number] => 06248579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins' [patent_app_type] => 1 [patent_app_number] => 9/372934 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 31401 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248579.pdf [firstpage_image] =>[orig_patent_app_number] => 372934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4286145 [patent_doc_number] => 06268216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Reagents and methods for the screening of compounds useful in the treatment of neurological diseases' [patent_app_type] => 1 [patent_app_number] => 9/360779 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 19484 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268216.pdf [firstpage_image] =>[orig_patent_app_number] => 360779 [rel_patent_id] =>[rel_patent_doc_number] =>)